Artificial Intelligence, Broad Institute, Cancer, Computer science and technology, Diagnostics, Disease, Electrical Engineering & Computer Science (eecs), Health, Health care, IDSS, Laboratory for Information and Decision Systems (LIDS), Machine learning, MIT Schwarzman College of Computing, National Institutes of Health (NIH), Research, School of Engineering, UncategorizedJuly 24, 202437Views0Likes0Comments
Ductal carcinoma in situ (DCIS), a type of tumor that can develop into an aggressive form of breast cancer, accounts for approximately 25% of all breast cancer diagnoses. DCIS can be challenging for clinicians to accurately categorize, leading to frequent overtreatment for patients. A team of researchers from the Massachusetts Institute of Technology (MIT) and…
Mia, an Artificial Intelligence (AI) tool, demonstrates its potential by identifying undetected cancerous indications in mammograms. It is known that early detection is crucial in treating all types of cancer, especially those with a high spread rate. Mia has the ability to identify tiny tumors that are often unnoticeable to the human eye but can…
Five MIT researchers—Michael Birnbaum, Regina Barzilay, Brandon DeKosky, Seychelle Vos, and Ömer Yilmaz—are part of winning teams for Cancer Grand Challenges 2024. Each team, made up of international, interdisciplinary cancer researchers, will receive $25 million over five years.
Associate Professor of Biological Engineering Michael Birnbaum is heading Team MATCHMAKERS, comprised of co-investigators Regina Barzilay (Engineering Distinguished…
MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) scientists, in collaboration with Limor Appelbaum, a scientist in the Department of Radiation Oncology at Beth Israel Deaconess Medical Center (BIDMC), have developed two machine-learning models for the early detection of pancreatic cancer. The two models PRISM and the logistic regression model both surpassed current diagnostic methods.…